FDA pulls authorization for AstraZeneca’s Covid antibody drug Evusheld

[ad_1] The Food and Drug Administration has withdrawn emergency use authorization for AstraZeneca’s Covid-19 antibody cocktail Evusheld as the treatment is not expected to neutralize the currently dominant XBB.1.5 subvariant of…